Although complications associated with peripheral vascular devices are typically minor, some infants may experience life-threatening sequelae or serious and prolonged alterations in function.

MRI-Compatible IV Infusion Pump Systems MarketThe global market for MRI-compatible IV infusion pump systems is set for significant expansion, driven by advancements in medical imaging and increasing ...

Even those PEPFAR programs operating must limit distribution of preventive medication, according to apparent State Department ...

California medical device company RenovoRx’s Trans-Arterial Micro-Perfusion (TAMP) system has shown potential for improved ...

RenovoRx (Nasdaq:RNXT) announced that it priced an underwritten public offering of common stock worth proceeds of $12.1 ...

Becton, Dickinson & Co. plans to close its Caesarea Medical Electronics, a producer of infusion pump systems, by June and ...

Global Intraosseous Devices Market Set for Significant Growth, Projected to Reach USD 938.6 Million by 2035 Driven by Growing Demand and Technological Advancements. The U.S. leads the intraosseous ...

It's the first and only such therapy approved to fight antimicrobial resistance, or AMR, in bacterial infections.

Leqembi and Kisunla are given as an intravenous (IV) infusion, meaning patients and caretakers often must travel ... If approved, the injectable version would come packaged in an autoinjector device ...

Dr Reddy's Laboratories has signed a licence agreement with Shanghai Henlius Biotech to develop and commercialise HLX15.

A new treatment for colorectal cancer that has spread to the liver is showing promising results in Dutch medical trials. The ...